Skip to evidence report

NEU.INH_VIP.develop_niche: Studies — page 6

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 122 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 5,001–6,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for NEU.INH_VIP.develop_niche
#Trait / studyIndividual trait IDMean IC score
5001OLR1 levelsGCST904701220.11
5002CTRB1 levelsGCST904689050.11
5003FKBP1B/TGFB1 ratioGCST903148360.11
5004Hemoglobin A1c levelsGCST900187380.11
5005MED18 levelsGCST904698800.11
5006Total cholesterol levels in medium VLDLGCST901326890.11
5007Concentration of medium LDL particles (UKB data field 23537)GCST902696340.11
5008IDP dMRI TBSS FA Tapetum RGCST900039230.11
5009MIF levelsGCST900890180.11
5010Cholesterol to total lipids ratio in very large VLDLGCST900930170.11
5011Sphingomyelin_33:1_[M+H]1+ levelsGCST900602290.11
5012eGFR in diabetes mellitus (loose) (minimal adjustment)GCST906247830.11
5013Haemorrhoids | Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classifiedUKBB000002940.11
5014Triacylglycerol_53:2_[M+NH4]1+ levelsGCST900605310.11
5015SNX5 levelsGCST904707020.11
5016High light scatter reticulocyte percentage | Blood countUKBB000003270.11
5017Autorefraction - 3mm weak meridian (right) | EyesightUKBB000000700.11
5018IDP dMRI TBSS MO Anterior corona radiata RGCST900039740.11
5019Glycated haemoglobin (HbA1c) | Blood biochemistryUKBB000002890.11
5020Volume of right central nucleusGCST904750240.11
5021T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 28)GCST903208470.11
5022GMFG levelsGCST904693660.11
5023Bicarbonate (maximum, inv-norm transformed)GCST904751450.11
5024Diacylglycerol_34:2_[M+H-H2O]1+ levelsGCST900601780.11
5025Medication for pain relief, constipation, heartburn - Ibuprofen (e.g. Nurofen) | MedicationUKBB000004550.11
5026Tooth agenesis EXCLUDE clefts and syndromesFING000013680.11
5027DTI TBSS FA Posterior thalamic radiation LGCST903844090.11
5028wg rh intensity-contrast fusiformGCST900038330.11
5029CDH17/PECAM1 ratioGCST903139420.11
5030HNRNPUL1 levelsGCST904694700.11
5031Glucose levelsGCST900187350.11
5032Codeine or tramadol medicationFING000003110.11
5033Primary coxarthrosis, bilateralFING000012120.11
5034T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 124)GCST903206870.11
5035IDP dMRI TBSS OD Posterior limb of internal capsule RGCST900044200.11
5036DTI autoptx FA ptr l tractGCST903851310.11
5037Pain and other conditions associated with female genital organs and menstrual cycleFING000011360.11
5038Acute upper respiratory infections of multiple and unspecified sitesFING000000350.11
5039Cholesteryl Esters to Total Lipids in Large HDL percentageGCST904977680.11
5040CRTAM/FCRL6 ratioGCST903142740.11
5041GRP levelsGCST902412420.11
5042IL1RL1 levelsGCST902415810.11
5043APOA levelsGCST904680610.11
5044CDH17/DSG2 ratioGCST903139390.11
5045CELA2A levelsGCST904687010.11
5046MESD/VASH1 ratioGCST903154250.11
5047Phospholipids in LDLGCST904984320.10
5048Hair colour (natural, before greying): Black (UKB data field 1747_5)GCST900418400.10
5049Osteomyelitis (PheCode 710.1)GCST904762210.10
5050Triglyceride levelsGCST902786450.10
5051RND3 levelsGCST904222300.10
5052Oral glucose tolerance test-1hGCST902977890.10
5053CLEC1B/NSFL1C ratioGCST903140990.10
5054Total lipids in chylomicrons and extremely large VLDL (UKB data field 23482)GCST902695790.10
5055Monounsaturated fatty acids to total fatty acids percentageGCST905020430.10
5056CPA1 levelsGCST904688360.10
5057Right ventricular peak atrial filling rateGCST902681190.10
5058AK1/NSFL1C ratioGCST903132240.10
5059Cholesterol in small LDL (UKB data field 23547)GCST902696440.10
5060Cholesterol esters in very large HDLGCST905003540.10
5061DTI autoptx L3 slf l tractGCST903852140.10
5062CD79B/ICAM3 ratioGCST903139010.10
5063aseg global volume CSFGCST900026030.10
5064GPKOW levelsGCST904693920.10
5065KLK14 levelsGCST904274280.10
5066Cholesteryl esters to total lipids ratio in medium VLDLGCST900929190.10
5067Total lipid levels in medium LDLGCST900929100.10
5068EPO/TFRC ratioGCST903146840.10
5069Diastolic blood pressureGCST904727780.10
5070MASP1 levelsGCST904698630.10
5071MAX/STK24 ratioGCST903154040.10
5072DTI TBSS L2 Posterior thalamic radiation LGCST903845050.10
5073CSF2 levelsGCST904688840.10
5074Deferral due to hypohemoglobinemia in blood donorsGCST901041130.10
5075Prescriptions - antispasmodicUKBB000006660.10
5076Any dementia (more control exclusions)FING000000990.10
5077Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T92ECGA0000920.10
5078SRP14 levelsGCST904707420.10
5079Free cholesterol to total lipids in IDL percentage (UKB data field 23612)GCST902697090.10
5080QC T1-to-standard nonlinear alignment discrepancyGCST900063460.10
5081Left ventricular end systole inferior wall thicknessGCST902785090.10
5082wg lh intensity-contrast lateraloccipitalGCST900038020.10
5083STAT5B levelsGCST904707590.10
5084CLPP levelsGCST904687850.10
5085Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T76ECGU0000760.10
5086Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T172ECGU0001720.10
5087ECHDC3 levelsGCST904690620.10
5088DTI autoptx L3 slf r tractGCST903852150.10
5089CNDP1 levelsGCST904687960.10
5090TNFRSF1A levelsGCST900120150.10
5091Pain medicine use during menstruationGCST0066370.10
5092Autorefraction - 3mm weak meridian (left) | EyesightUKBB000000690.10
5093aparc-Desikan rh area lingualGCST900031190.10
5094DOK2/GRAP2 ratioGCST903145310.10
5095CFB levelsGCST902407780.10
5096Cholesteryl esters in large HDL (UKB data field 23562)GCST902696590.10
5097HEXIM1/TBL1X ratioGCST903150530.10
5098Cholesteryl esters to total lipids ratio in medium LDLGCST900929070.10
5099Cholesteryl esters in small VLDL (UKB data field 23513)GCST902696100.10
5100Cholesterol to Total Lipids in Large HDL percentageGCST904977320.10
51011-arachidonoylglycerophosphoinositol levelsGCST902437540.10
5102Systolic blood pressureGCST903102940.10
5103T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 63)GCST903208820.10
5104Diabetes mellitus (UKB data field 2443)GCST900436270.10
5105wg rh intensity-contrast superiorfrontalGCST900038540.10
5106EGLN1/PIK3AP1 ratioGCST903146190.10
5107Cholesterol levels in medium LDLGCST900929040.10
5108Left-hemisphere salience/ventral attention network to thalamus white-matter structural connectivityGCST903027190.10
5109CAMK1D levelsGCST902405560.10
5110T1 CAT volume L LateralOccipitalCortexinferiordivisionGCST903840440.10
5111MAP2K1 levelsGCST904698510.10
5112GALNT10/IGSF3 ratioGCST903149140.10
5113T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 117)GCST903206800.10
5114DTI autoptx L1 ifo r tractGCST903851520.10
5115ICD10 O26.6: Liver disorders in pregnancy, childbirth and puerperiumGCST904542370.10
5116CTRL levelsGCST904689070.10
5117Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T207ECGU0002070.10
5118PVR levelsGCST904703940.10
5119Volume of right basal nucleusGCST904750120.10
5120Congenital malformations of genital organsFING000003330.10
5121Medication use (antithrombotic agents)GCST900187620.09
5122Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T2ECGU0000020.09
5123T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 66)GCST903208850.09
5124Been in a confiding relationship as an adult | Traumatic eventsUKBB000000880.09
5125APOM/MCAM ratioGCST903133150.09
5126Docosahexaenoic acid to total fatty acids percentageGCST905022800.09
5127KeloidGCST906524880.09
5128PSAPL1 levelsGCST904703500.09
5129GLO1 levelsGCST904693580.09
5130aparc-pial rh area lingualGCST900031860.09
5131Sleep apnea with BMI < 30GCST906247970.09
5132wg lh intensity-contrast frontalpoleGCST900038230.09
5133PDGFB/SNAP29 ratioGCST903156270.09
5134FGF19 levelsGCST904692200.09
5135DIABLO/PDGFB ratioGCST903144680.09
5136Follicle stimulating hormone levelsGCST904834760.09
5137Linoleic acid to total fatty acids percentageGCST905020170.09
5138Cholesteryl ester levels in small LDLGCST900929580.09
5139Total lipid levels in medium VLDLGCST900929220.09
5140Free androgen indexGCST902398230.09
5141Other bacterial diseasesFING000009680.09
5142Total cholesterol response to statins (relative logarithmic difference)GCST904556080.09
5143Total cerebellar volume (excluding Crus I vermis)GCST900201900.09
5144LPCAT2 levelsGCST902418410.09
5145Cholesterol levels in very large VLDLGCST905005170.09
5146DOK2/PDLIM7 ratioGCST903145350.09
5147MUC13 levelsGCST904699630.09
5148ITGB1/TFPI ratioGCST903152310.09
5149Other disorders of eyelids (PheCode 374)GCST904758900.09
5150LDL cholesterol levelsGCST904983460.09
5151Haematocrit percentage (UKB data field 30030)GCST904680730.09
5152(R)-3-hydroxybutyrylcarnitine levelsGCST901999300.09
5153Total lipids in large HDLGCST904978150.09
5154Triglycerides in small LDL (UKB data field 23550)GCST902696470.09
5155OtosclerosisGCST901295750.09
5156GBP6 levelsGCST902413680.09
5157EFEMP1/TGFBR3 ratioGCST903145970.09
5158Estradiol levelsGCST900121050.09
5159Liver condition (ex. cirrhosis)GCST904752700.09
5160wg lh intensity-contrast postcentralGCST900038130.09
5161Macular degeneration, wet (PheCode 362.22)GCST904758520.09
5162Biological Mother: Cancer, SkinGCST904754870.09
5163MMP13 levelsGCST904699170.09
5164Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T91ECGA0000910.09
5165SIL1 levelsGCST904706380.09
5166FSTL3/SPON2 ratioGCST903148840.09
5167HGF/PDGFB ratioGCST903150580.09
5168aparc-pial rh area lateraloccipitalGCST900031840.09
5169CCR2 on CD14+ CD16- monocyteGCST900020040.09
5170Cholesteryl esters to total lipids in medium VLDL percentage (UKB data field 23596)GCST902696930.09
5171Cholesterol to Total Lipids in IDL percentageGCST904975180.09
5172Type 1 diabetesGCST904320660.09
5173CASP3/PDGFA ratioGCST903136370.09
5174Concentration of small LDL particles (UKB data field 23544)GCST902696410.09
5175Cholesterol in medium LDL (UKB data field 23540)GCST902696370.09
5176Linoleic acid to total fatty acids percentage (UKB data field 23456)GCST902695530.09
5177Other disorders of circulatory system | circulatory systemUKBB000006070.09
5178CFI levelsGCST904687300.09
5179Phospholipids in medium VLDL (UKB data field 23504)GCST902696010.09
5180CEP170 levelsGCST904687110.09
5181Phosphatidylinositol (20:0_20:4) levelsGCST900250830.09
5182T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 45)GCST903206080.09
5183Omega-3 fatty acids to total fatty acids percentageGCST904991550.09
5184Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T443ECGU0004430.09
5185Deep endometriosisFING000003820.09
5186SERPINC1 levelsGCST904705940.09
5187TNFSF10 levelsGCST904709170.09
5188Phospholipids in medium HDLGCST904986350.09
5189Left-hemisphere limbic network to amygdala white-matter structural connectivityGCST903027410.09
5190Phospholipids in very large VLDLGCST905006440.09
5191CXCL16 levelsGCST902405240.09
5192Other heart diseasesFING000010570.09
5193T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 98)GCST903206610.09
5194Omega-6 fatty acid levelsGCST905025020.09
5195Calculus of kidney | genitourinaryUKBB000001150.09
5196Autorefraction - 6mm asymmetry angle (left) | EyesightUKBB000000720.09
5197Linoleic acid to total fatty acids percentageGCST905023200.09
5198rfMRI amplitudes (ICA100 node 35)GCST900046230.09
5199Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T457ECGU0004570.09
5200T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 51)GCST903206140.09
5201Treatment/medication code - lisinopril | MedicationsUKBB000008500.09
5202Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)FING000008640.09
5203Fasting glucoseGCST902786280.09
5204CA1/TGM2 ratioGCST903135750.09
5205Hypercalcemia (PheCode 275.6)GCST904757480.09
5206NPHS2 levelsGCST904700710.09
5207X-21471 levelsGCST902005860.09
5208ADAMTS4 levelsGCST904682260.09
5209Linoleic acid levelsGCST905022940.09
5210Enteropathic arthropathiesFING000005080.09
5211Concentration of large LDL particlesGCST904980370.09
5212Saturated fatty acids to total fatty acids percentageGCST905021990.09
5213DEFA1_DEFA1B/LCN2 ratioGCST903144540.08
5214MAMDC4 levelsGCST904698420.08
5215Polyunsaturated fatty acids to saturated fatty acids ratioGCST905025800.08
5216IGFBPL1 levelsGCST904695330.08
5217Chronic obstructive pulmonary diseaseGCST900185870.08
5218HPCAL1/LAT ratioGCST903150720.08
5219Cholesterol levels in very small VLDLGCST905007120.08
5220Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T203ECGA0002030.08
5221Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T100ECGU0001000.08
5222Iliac isthmus breadthGCST904489070.08
5223MCAM/NTRK3 ratioGCST903154090.08
5224Vertical cup-disc ratioGCST0040750.08
5225Type 1 diabetesGCST900140230.08
5226COX5B/FXN ratioGCST903141990.08
5227KLK4 levelsGCST904697040.08
5228Acute pancreatitisFING000000270.08
5229Longitudinal peak diastolic strain rateGCST900190130.08
5230Iron deficiency anemia secondary to blood loss (chronic) (PheCode 280.2)GCST904757700.08
5231Abscess of anal and rectal regionsFING000000050.08
5232GSTA1/KRT18 ratioGCST903149930.08
5233Cholesterol to Total Lipids in Small LDL percentageGCST904995690.08
5234Mean corpuscular volume | Blood countUKBB000004490.08
5235THOP1 levelsGCST904708560.08
5236Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T448ECGU0004480.08
5237Breast cancerGCST900118040.08
5238SERPINI2 levelsGCST904706030.08
5239NID1/TIMP3 ratioGCST903155430.08
5240Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T463ECGU0004630.08
5241CCBL2 levelsGCST902417220.08
5242FADD/MGLL ratioGCST903147680.08
5243IDP dMRI TBSS L3 FornixGCST900041760.08
5244CSTB levelsGCST901792720.08
5245MPO levelsGCST904699370.08
5246Right ventricular end systolic volumeGCST901345890.08
5247IDP dMRI TBSS FA Sagittal stratum LGCST900039080.08
5248DBNL/VASH1 ratioGCST903144270.08
5249TNFRSF10A levelsGCST904708990.08
5250Osteoarthritis (hip)GCST0070910.08
5251AGXT/GSTA1 ratioGCST903132060.08
5252Phospholipids to total lipids ratio in medium LDLGCST900929130.08
5253Cholesterol esters in very small VLDLGCST905007490.08
5254MMP7 levelsGCST904699210.08
5255Volume of right lateral nucleusGCST904750390.08
5256Saturated fatty acids to total fatty acids percentageGCST905027000.08
5257Phosphatidylcholine diacyl C36:4 levelsGCST902400400.08
5258Diabetes diagnosed by doctor | Medical conditionsUKBB000001680.08
5259F7/F9 ratioGCST903147430.08
5260CRLF1 levelsGCST904688680.08
5261T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 89)GCST903206520.08
5262IDP dMRI ProbtrackX MD cst rGCST900042280.08
5263LTBP2/PDGFRA ratioGCST903153380.08
5264SPOCK2 levelsGCST902429870.08
5265Cholesteryl Esters in LDLGCST904983740.08
5266BPIFB1/GLRX ratioGCST903135300.08
5267T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 110)GCST903209290.08
5268Concentration of very small VLDL particles (UKB data field 23516)GCST902696130.08
5269MVK/SERPINE1 ratioGCST903155050.08
5270T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 36)GCST903208550.08
5271Blood cell traits latent factor 14 (red cell)GCST905592560.08
5272Average diameter for VLDL particlesGCST905002900.08
5273ITIH3 levelsGCST904696500.08
5274Triglycerides in medium VLDLGCST904990650.08
5275ASGR1/GGT5 ratioGCST903133650.08
5276Triglycerides to total lipids ratio in small VLDLGCST900929790.08
5277PRDX5 levelsGCST904703180.08
5278Volume of right whole amygdalaGCST904750540.08
5279CCL4 levelsGCST900120520.08
5280Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T222ECGU0002220.08
5281T1 FreeSurfer a2009s lh G cuneus areaGCST903846780.08
5282Birth weightGCST0075570.08
5283BA-exvivo rh volume BA3bGCST900028520.08
5284Phospholipids in medium HDLGCST904986410.08
5285PLAUR levelsGCST904702510.08
5286total creatine kinase (maximum, inv-norm transformed)GCST904764100.08
5287EBAG9/HBEGF ratioGCST903145650.08
5288T1 FreeSurfer DKT rh pericalcarine areaGCST903843050.08
5289Sleep apnea syndromeGCST902673610.08
5290SFTPD levelsGCST904706140.08
5291Heart failure, strictFING000006060.08
5292Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T462ECGU0004620.08
5293Hair colour (natural, before greying): Light brown (UKB data field 1747_3)GCST900418380.08
5294Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T173ECGU0001730.08
5295Biological Sibling: Alzheimer's / Other DementiaGCST904763750.08
5296IZUMO4 levelsGCST904237920.08
5297T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 123)GCST903206860.08
5298ThalamNuclei lh volume PuIGCST900027140.08
5299Triglycerides in very large HDLGCST905004820.08
5300HDL x low social support interaction (2df test)GCST905706690.08
5301AKT3 levelsGCST904682780.08
5302Free cholesterol in chylomicrons and extremely large VLDL (UKB data field 23486)GCST902695830.08
5303TNFRSF13C levelsGCST904709060.08
5304MAPRE3 levelsGCST904698590.08
5305LBP levelsGCST904697430.08
5306Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T99ECGU0000990.08
5307T1 FreeSurfer DK rh supramarginal volumeGCST903857870.07
5308FURIN/INHBC ratioGCST903148860.07
5309T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 5)GCST903205680.07
53101-(1-enyl-palmitoyl)-2-linoleoyl-GPC (p-16:0/18:2) levelsGCST902000600.07
5311VEGFD levelsGCST900120690.07
5312Straight vs curly hairGCST0060940.07
5313EPHB6/TNFRSF9 ratioGCST903146820.07
5314ECG, heart rate | ECG during exerciseUKBB000002040.07
5315BCR/ICA1 ratioGCST903134930.07
5316aseg lh volume Inf-Lat-VentGCST900026170.07
5317Other disorders of amino-acid metabolismFING000010140.07
5318Macular puckering of retina (PheCode 362.26)GCST904758540.07
5319Other hammer toe(s) (acquired)FING000010540.07
5320Total triglycerides levelsGCST900929920.07
5321Total Lipids in LDLGCST904983960.07
5322CTSO levelsGCST901792770.07
5323CAG-177 sp003538135 abundance in stoolGCST900322600.07
5324Senile cataractFING000012900.07
5325Total lipids in small LDLGCST904996520.07
5326LGALS7_LGALS7B/WFDC12 ratioGCST903153170.07
5327Coeliac diseaseFING000003120.07
5328CTRC levelsGCST904689060.07
5329Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T229ECGU0002290.07
5330BCR/VASH1 ratioGCST903134990.07
5331Concentration of very small VLDL particlesGCST900930350.07
5332Free cholesterol to total lipids ratio in chylomicrons and extremely large VLDLGCST900930450.07
5333IDP dMRI ProbtrackX L3 cst lGCST900043080.07
5334PTPRR levelsGCST904703860.07
5335Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T450ECGU0004500.07
5336DIPK2B levelsGCST904689960.07
5337aparc-a2009s rh area S-parieto-occipitalGCST900034350.07
5338Average diameter for LDL particlesGCST904984570.07
5339Mean corpuscular hemoglobinGCST900187440.07
5340Valine levelsGCST902434530.07
5341Coxarthrosis, primaryFING000003630.07
5342DAG1/HBEGF ratioGCST903143760.07
5343Other and unspecified polyneuropathies, also in other diseasesFING000009480.07
5344Parental longevity (mother's attained age)GCST0066960.07
5345rfMRI amplitudes (ICA100 node 28)GCST900046160.07
5346Phosphatidylcholine-O_31:0_[M+H]1+/Phosphatidylethanolamine-O_34:0_[M+H]1+ levelsGCST900602430.07
5347T1 FreeSurfer DKT lh superiortemporal thicknessGCST903842520.07
5348PPT1 levelsGCST904277180.07
5349MAD1L1/POLR2F ratioGCST903153540.07
5350Recent feelings of inadequacy | DepressionUKBB000007390.07
5351X-16087 levelsGCST902005370.07
5352Lactate levels (UKB data field 23471)GCST902695680.07
5353Phospholipids to total lipids in large VLDL percentage (UKB data field 23589)GCST902696860.07
5354IDP dMRI TBSS MD FornixGCST900040320.07
5355IFNGR1/THBD ratioGCST903151300.07
5356EFNB2 levelsGCST904690820.07
5357MYOM2 levelsGCST904699850.07
5358Phosphatidylcholine_36:5_[M+H]1+/Phosphatidylethanolamine_39:5_[M+H]1+/Phosphatidate_41:6_[M+NH4]1+ levelsGCST900603450.07
5359IDP dMRI TBSS FA FornixGCST900038820.07
5360Cholesterol in Medium VLDLGCST904989030.07
5361Free cholesterol in medium VLDLGCST904989650.07
5362AXIN1/IKBKG ratioGCST903134090.07
5363Glucose levelsGCST900928190.07
5364Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T9ECGU0000090.07
5365Total lipids in medium LDL (UKB data field 23538)GCST902696350.07
5366LAMA4 levelsGCST904697310.07
5367EPCAM levelsGCST904691260.07
5368PSME1 levelsGCST904703600.07
5369SEMA4C levelsGCST904705720.07
5370Pyruvate levels (UKB data field 23472)GCST902695690.07
5371Triglycerides to total lipids ratio in very large VLDLGCST900930270.07
5372Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T66ECGU0000660.07
5373Lactate levelsGCST900928820.07
5374CRKL/PLA2G4A ratioGCST903142710.07
5375ICD10 N83.0, N83.1, N83.2: Ovarian cyst, including follicular cyst, corpus luteum cyst, and other/unspecified ovarian cystGCST904542150.07
5376Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T77ECGU0000770.07
5377Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T447ECGU0004470.07
5378Docosahexaenoic acid levelsGCST905022540.07
5379DTI TBSS L2 Uncinate fasciculus LGCST903845210.07
5380Illnesses of father - Diabetes | Family historyUKBB000003410.07
5381Type1 diabetes, definitions combined, early onsetFING000013840.07
5382PROC levelsGCST904703350.07
5383Phosphatidylcholine_38:5_[M+H]1+/Phosphatidylethanolamine_41:5_[M+H]1+/Phosphatidate_43:6_[M+NH4]1+ levelsGCST900603950.07
5384T1 FreeSurfer DKT rh supramarginal volumeGCST903843770.07
5385Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T128ECGU0001280.07
5386Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T241ECGU0002410.07
5387DTI autoptx MD ptr r tractGCST903852400.07
5388VLDL cholesterol levels (UKB data field 23403)GCST902695000.07
5389Omega-6 fatty acids to total fatty acids percentageGCST905025440.07
5390wg lh intensity-contrast fusiformGCST900037980.07
5391CD58/ROR1 ratioGCST903138540.07
5392Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T174ECGU0001740.07
5393Butyrylcarnitine levelsGCST902435890.07
5394Pulmonary tuberculosisGCST900186720.07
5395Ratio of linoleic acid to total fatty acidsGCST900928810.07
5396Cholesteryl esters in very large VLDLGCST905005560.07
5397CELA3A/CPA1 ratioGCST903140090.07
5398Triglycerides to total lipids in small VLDL percentage (UKB data field 23603)GCST902697000.07
5399F10 levelsGCST904691630.07
5400A1BG levelsGCST904681850.07
5401Dupuytren's diseaseGCST903012520.07
5402CEP43 levelsGCST904687150.07
5403Benign leiomyoma with endometriosis (controls excluding all cancers)FING000001450.07
5404ICD10 N81: Female genital prolapseGCST904542140.07
5405Cholesteryl esters in small LDL (UKB data field 23548)GCST902696450.07
5406Prescriptions - ACE inhibitor|anti-hypertensiveUKBB000006570.07
5407Total testosterone levelsGCST900121130.07
5408Job SOC coding: Heavy goods vehicle drivers (UKB data field 22617_8211)GCST900435520.07
5409CD55/PTGDS ratioGCST903138470.07
5410DTI TBSS FA Uncinate fasciculus LGCST903844250.07
5411Urinary incontinence (PheCode 599.4)GCST904761520.07
5412T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 68)GCST903208870.07
5413RAB10 levelsGCST904704030.07
5414Degree of unsaturationGCST905027480.06
5415Polyunsaturated fatty acid levelsGCST904992710.06
5416Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T213ECGU0002130.06
5417aparc-pial lh area parstriangularisGCST900031600.06
5418wg rh intensity-contrast parstriangularisGCST900038460.06
5419Total Dihexosylceramide levelsGCST900258210.06
5420CALCB levelsGCST904685290.06
5421MANF levelsGCST904698460.06
5422Omega-6 fatty acid levelsGCST900929330.06
5423aseg lh volume choroid-plexusGCST900026290.06
5424Free cholesterol in very small VLDLGCST905007740.06
5425AGRP/CCN1 ratioGCST903132020.06
5426Total lipid levels in lipoprotein particlesGCST900929890.06
5427Cystatin C productionGCST902679860.06
5428T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 116)GCST903209350.06
5429Left ventricular end diastole inferoseptal wall thicknessGCST902785140.06
5430Cholesteryl esters to total lipids in large LDL percentage (UKB data field 23616)GCST902697130.06
5431Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T211ECGU0002110.06
5432Cholesterol levels in small HDLGCST900929440.06
5433Forced expiratory volume in 1-second (FEV1), predicted | SpirometryUKBB000002520.06
5434PI3 levelsGCST904702300.06
5435DTI TBSS MD Superior fronto-occipital fasciculus LGCST903846150.06
5436DTI TBSS MO Medial lemniscus RGCST903846280.06
5437Omega-3 fatty acid levelsGCST905024370.06
5438Total lipids in small LDL (UKB data field 23545)GCST902696420.06
5439QPCT/RNASET2 ratioGCST903157580.06
5440PITHD1 levelsGCST904702390.06
5441red cell diameter width (RDW, mean, inv-norm transformed)GCST904763610.06
5442CANT1/HSPB1 ratioGCST903136170.06
5443Chronic lower respiratory diseasesFING000002900.06
5444Cylindrical power (right) | AutorefractionUKBB000001620.06
5445Triglyceride levels in medium LDLGCST900929140.06
5446wg rh intensity-contrast inferiorparietalGCST900038340.06
5447Height (weighted GWA)GCST902672850.06
5448Omega-6 fatty acid levelsGCST905020940.06
5449GFER/TRIAP1 ratioGCST903149210.06
5450CDH17/SPINT1 ratioGCST903139440.06
5451INSR levelsGCST902415090.06
5452Osteochondrodysplasia with defects of growth of tubular bones and spineFING000009100.06
5453Plasma pregnenetriol sulfate* levels in chronic kidney diseaseGCST902658660.06
5454Cholesterol levels in chylomicrons and extremely large VLDLGCST905009180.06
5455AMY2B levelsGCST904682990.06
5456Cholesteryl esters to total lipids in large VLDL percentage (UKB data field 23591)GCST902696880.06
5457Free cholesterol to total lipids ratio in very small VLDLGCST900930330.06
5458GP1BA levelsGCST904693800.06
5459Physical activityGCST900933240.06
5460Shoulder width to body height ratioGCST902702610.06
5461Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T243ECGU0002430.06
5462CRIP2/SNCG ratioGCST903142620.06
5463Concentration of small VLDL particles (UKB data field 23509)GCST902696060.06
5464ABO levelsGCST904681910.06
5465Diabetes, insulin treatment (Kela reimbursement) (more control exclusions)FING000004100.06
5466aparc-DKTatlas rh volume precentralGCST900029150.06
5467Suggestive for eosinophilic asthmaFING000013440.06
5468Rhodanobacter abundance in stoolGCST900325360.06
5469APP/FKBP1B ratioGCST903133230.06
5470Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T242ECGU0002420.06
5471Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T240ECGU0002400.06
5472FAM172A levelsGCST904691840.06
5473LECT2 levelsGCST904697510.06
5474Polyunsaturated fatty acids to saturated fatty acids ratioGCST905025960.06
5475Substance dependenceGCST900187040.06
5476Other retinal disordersFING000010940.06
5477Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T458ECGU0004580.06
5478DLK1/PIK3IP1 ratioGCST903144920.06
5479PDP1 levelsGCST904242960.06
5480Volume of left lateral nucleusGCST904748890.06
5481CA5A levelsGCST904685140.06
5482CNDP1/F9 ratioGCST903141470.06
5483Phospholipids in small VLDL (UKB data field 23511)GCST902696080.06
5484Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T200ECGA0002000.06
5485Glycated hemoglobin levelsGCST905664240.06
5486Concentration of very large HDL particles (UKB data field 23551)GCST902696480.06
5487GABBR2 levelsGCST902412300.06
5488Anal and rectal conditions | digestiveUKBB000000290.06
5489ANXA3/EDAR ratioGCST903132800.06
5490CASP3/PDGFB ratioGCST903136380.06
5491T1 FreeSurfer pial rh pericalcarine areaGCST903858420.06
5492Triglycerides in large HDLGCST904978880.06
5493Free cholesterol to total lipids in medium LDL percentage (UKB data field 23622)GCST902697190.06
5494Paraproteinemia (PheCode 270.32)GCST904757100.06
5495Acute appendicitis, with complicationsFING000000190.06
5496TNFRSF13C/TNFSF13B ratioGCST903159340.06
5497Cholesteryl esters to total lipids ratio in chylomicrons and extremely large VLDLGCST900930430.06
5498TEK levelsGCST900120130.06
5499Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T202ECGA0002020.06
5500Cholesteryl esters to total lipids ratio in very large VLDLGCST900930190.06
5501CD2AP/USP8 ratioGCST903137840.06
5502Pelvic inlet widthGCST904489100.06
5503wg lh intensity-contrast rostralmiddlefrontalGCST900038180.06
5504Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)FING000013300.06
5505Cholesterol in large VLDL (UKB data field 23498)GCST902695950.06
5506Umbilical herniaFING000013950.06
5507Monounsaturated fatty acid levelsGCST900929280.06
5508GFAP levelsGCST904693250.06
5509Diverticulitis (PheCode 562.2)GCST904760770.06
5510CDH17/PTPRM ratioGCST903139430.06
5511HDGF levelsGCST904694420.06
5512Total lipid levels in very small VLDLGCST900930340.06
5513S100G levelsGCST904705190.06
5514Phosphatidylethanolamine_35:2_[M-H]1- levelsGCST900602600.06
5515T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 115)GCST903206780.06
5516ERBIN/SNAP29 ratioGCST903146970.06
5517KLK8 levelsGCST904254920.06
5518T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 78)GCST903206410.06
5519PDCD5 levelsGCST904701820.06
5520C36:4 Phosphatidylethanolamine levels in chronic kidney diseaseGCST902573570.06
5521FCRL3 levelsGCST904692070.06
5522Subarachnoid haemorrhageFING000013390.06
5523DTI TBSS L2 Superior longitudinal fasciculus RGCST903845160.06
5524Free cholesterol in very large VLDL (UKB data field 23493)GCST902695900.06
5525Diastolic blood pressureGCST903016980.06
5526LMNB1 levelsGCST904697810.06
5527SHBG levelsUKBB000007670.06
5528Sphingomyelin_42:3_[M+H]1+ levelsGCST900603990.06
5529DTI TBSS MD Posterior thalamic radiation LGCST903846010.06
5530GonarthrosisFING000005850.06
5531Concentration of small HDL particlesGCST900929510.06
5532Cholesterol in very large VLDL (UKB data field 23491)GCST902695880.06
5533Cholesterol in chylomicrons and extremely large VLDL (UKB data field 23484)GCST902695810.06
5534Concentration of large HDL particles (UKB data field 23558)GCST902696550.06
5535PYDC1 levelsGCST904703970.06
5536wg lh intensity-contrast parstriangularisGCST900038110.06
5537Phospholipids to Total Lipids in Large HDL percentageGCST904978630.06
5538CD69/CHMP1A ratioGCST903138680.06
5539Phospholipids in small LDLGCST904996730.06
5540ENTPD5 levelsGCST902410240.06
5541Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T1ECGU0000010.06
5542DTI autoptx L1 ilf l tractGCST903851530.06
5543Cholesterol in large HDL (UKB data field 23561)GCST902696580.06
5544PDGFRA levelsGCST904210930.06
5545Chronic obstructive pulmonary disease liability (machine learning-based score)GCST902440980.06
5546Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T168ECGU0001680.06
5547Cholesteryl Esters in Medium VLDLGCST904989390.06
5548Illnesses of father - Heart disease | Family historyUKBB000003420.06
5549Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classifiedFING000004310.05
5550Linoleic acid levelsGCST905020090.05
5551aparc-DKTatlas lh volume parsopercularisGCST900028780.05
5552CRADD/DARS1 ratioGCST903142340.05
5553PIK3AP1 levelsGCST904702330.05
5554F2R levelsGCST904691680.05
5555Concentration of medium LDL particlesGCST900929110.05
5556Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T7ECGU0000070.05
5557aparc-a2009s rh volume G-cuneusGCST900030090.05
5558NCK2/VASH1 ratioGCST903155260.05
5559Hypertension, essentialFING000006380.05
5560OLR1/OSM ratioGCST903155830.05
5561Actinic keratosis (PheCode 702.1)GCST904762040.05
5562Peak expiratory flow (UKB data field 3064)GCST904681760.05
5563Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T171ECGU0001710.05
5564ALB levelsGCST900187250.05
5565Cholesteryl ester levels in medium LDLGCST900929060.05
5566Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T212ECGU0002120.05
5567Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T162ECGU0001620.05
5568Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T204ECGA0002040.05
5569Rash and other nonspecific skin eruption (PheCode 687.1)GCST904761670.05
5570MELTF levelsGCST904698850.05
5571APP/LAMA4 ratioGCST903133250.05
5572Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T4ECGU0000040.05
5573Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905021470.05
5574Operative procedures - Insertion of prosthetic replacement for lens NEC | Summary OperationsUKBB000005830.05
5575Pelvic widthGCST904489110.05
5576Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T470ECGU0004700.05
5577ECM1 levelsGCST904690650.05
5578Lung function (FEV1/FVC)GCST900259780.05
5579COQ7 levelsGCST904688310.05
5580LCAT levelsGCST904697450.05
5581Benign lipomatous neoplasm of skin and subcutaneous tissue of trunkFING000001500.05
5582GFER/VASH1 ratioGCST903149220.05
5583Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T169ECGU0001690.05
5584MLN/TNFRSF12A ratioGCST903154590.05
5585CD46/THBD ratioGCST903138360.05
5586Biological Mother: Cancer, BreastGCST904754850.05
5587NCS1/NPY ratioGCST903155270.05
5588Volume of left cortical nucleusGCST904749640.05
5589ThalamNuclei lh volume PuAGCST900027200.05
5590BCL2L11/VASH1 ratioGCST903134850.05
5591Height (standard GWA)GCST902672840.05
5592Hair colour (natural, before greying) - Dark brown | Sun exposureUKBB000002970.05
5593Lysine levelsGCST902004020.05
5594Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T8ECGU0000080.05
5595SNAP25 levelsGCST904220830.05
5596aparc-Desikan rh volume cuneusGCST900028050.05
5597Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T70ECGU0000700.05
5598T1 FreeSurfer DK lh superiortemporal thicknessGCST903856510.05
5599Phospholipids in medium LDLGCST904988320.05
5600IRAK1/SPRY2 ratioGCST903151960.05
5601DTI autoptx MD str l tractGCST903852430.05
5602Mean volume of bilateral amygdalaGCST904749940.05
5603ITGB1/NCAM1 ratioGCST903152270.05
5604T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 75)GCST903208940.05
5605Late-onset myasthenia gravisGCST904321580.05
5606N6-methyllysine levels in chronic kidney diseaseGCST902575300.05
5607Other noninfective gastroenteritis and colitisFING000010770.05
5608CD19 on IgD- CD27- B cellGCST900017320.05
5609Aplastic anemiaGCST900185740.05
5610IDP dMRI ProbtrackX ICVF ptr lGCST900043940.05
5611BIN1 levelsGCST900907570.05
5612CHMP1A levelsGCST906190020.05
5613T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 128)GCST903209470.05
5614C2/LILRB4 ratioGCST903135540.05
5615Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T440ECGU0004400.05
5616Spondylolisthesis/SpondylolysisFING000013240.05
5617Volume of right cortical nucleusGCST904750300.05
5618HBEGF levelsGCST900120670.05
5619Fracture of shoulder and upper armFING000005590.05
5620BA-exvivo rh area MTGCST900032320.05
5621T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 82)GCST903209010.05
5622IDP T1 FAST ROIs R temporal poleGCST900024660.05
5623T1 FreeSurfer BA lh V1 exvivo areaGCST903855140.05
5624Triglycerides in small VLDL (UKB data field 23515)GCST902696120.05
5625Breast cancerGCST0100980.05
5626IRF3 levelsGCST906187430.05
5627Cholesteryl esters to total lipids in medium LDL percentage (UKB data field 23621)GCST902697180.05
5628Total lipids in small VLDL (UKB data field 23510)GCST902696070.05
5629Trunk predicted mass | Impedance measuresUKBB000008660.05
5630Oblique pelvic inlet lengthGCST904489090.05
5631aparc-a2009s rh area Pole-occipitalGCST900034120.05
5632DLK1/FAP ratioGCST903144910.05
5633Heart failure and coronary heart diseaseFING000006040.05
5634Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483)GCST902695800.05
5635BCL2L11 levelsGCST904684300.05
5636Other menopausal disordersFING000010710.05
5637CDH15 levelsGCST904686680.05
5638IDP T1 FAST ROIs L temporal poleGCST900024650.05
5639Unspecified monoarthritis | musculoskeletalUKBB000008820.05
5640Bullous keratopathyFING000002310.05
5641T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 84)GCST903209030.05
5642Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T214ECGU0002140.05
5643Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T199ECGA0001990.05
5644PROK1 levelsGCST904703360.05
5645Hip circumference adjusted for BMIGCST0122270.05
5646Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T241ECGA0002410.05
5647SWAP70 levelsGCST902429310.05
5648LAT/SERPINE1 ratioGCST903152870.05
5649Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T151ECGU0001510.05
5650Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481)GCST902695780.05
5651Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T452ECGU0004520.05
5652Hallux valgus (Bunion) (PheCode 735.3)GCST904762510.05
5653Symptoms concerning nutrition, metabolism, and development (PheCode 1002)GCST904755560.05
5654Atrial fibrillation and flutter with reimbursementFING000001270.05
5655HYOU1/ROR1 ratioGCST903151040.05
5656Triglycerides x depression interaction (2df test)GCST905706790.05
5657AHSA1 levelsGCST904682620.05
5658CDKN1A levelsGCST904686840.05
5659HDAC8 levelsGCST904694380.05
5660Elevated prostate specific antigen [PSA] (PheCode 796)GCST904762770.05
5661CTSL levelsGCST900120730.05
5662SERPIND1 levelsGCST904705950.05
5663Free cholesterol to total lipids in large HDL percentage (UKB data field 23637)GCST902697340.05
5664ADH4/CA5A ratioGCST903131890.05
5665Other chondrocalcinosisFING000009770.05
5666CLEC1B/DIABLO ratioGCST903140870.05
5667Total lipids in VLDL (UKB data field 23424)GCST902695210.05
5668Concentration of medium VLDL particles (UKB data field 23502)GCST902695990.05
5669Unspecified osteomyelitis (PheCode 710.19)GCST904762240.05
5670PARK7/TNFRSF9 ratioGCST903155990.05
5671APOA4 levelsGCST904683330.05
5672DKK1/MGLL ratioGCST903144730.05
5673Alkaline phosphatase | Blood biochemistryUKBB000000270.05
5674Trunk fat-free mass | Impedance measuresUKBB000008650.05
5675CD300LG levelsGCST904686230.05
5676Free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23582)GCST902696790.05
5677AGXT levelsGCST904682580.05
5678SCLY levelsGCST904705460.05
5679Mandibular retrognathiaFING000007840.05
5680IDP T1 FAST ROIs R cerebellum VIGCST900025680.05
5681CRTAM/ICAM3 ratioGCST903142760.05
5682AARSD1/PIK3AP1 ratioGCST903131290.05
5683ACOX1/VSIR ratioGCST903131550.05
5684Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T210ECGU0002100.05
5685Congenital malformations of ovaries, fallopian tubes and broad ligamentsFING000003370.05
5686PLA2G4A/SPINT2 ratioGCST903156710.05
5687Uterine leiomyomataGCST902398560.05
5688HeightGCST900259490.05
5689S100A4/SNAP29 ratioGCST903158010.05
5690CLC/RNASE3 ratioGCST903140770.05
5691TPMT levelsGCST904709450.05
5692KCNA10 levelsGCST906178930.05
5693Ovarian cystFING000011320.05
5694Volume of right accessory basal nucleusGCST904750060.05
5695HDL cholesterol levelsGCST904973520.05
5696Triglycerides to total lipids in very large HDL percentage (UKB data field 23633)GCST902697300.05
5697Prostate cancerGCST904281170.05
5698Gastric polypGCST900186300.05
5699Asthma-related infectionsFING000001180.05
5700Cholesterol to Total Lipids in Small VLDL percentageGCST904997640.05
5701DTI TBSS L3 Superior corona radiata LGCST903845490.05
5702Treatment/medication code - gliclazide | MedicationsUKBB000008460.04
5703Artrosis, including avohilmoFING000001120.04
5704CLEC1A/TNFRSF1A ratioGCST903140850.04
5705Internal derangement of knee | injuries & poisoningsUKBB000003680.04
5706HayfeverGCST904681310.04
5707Saturated fatty acids to total fatty acids percentageGCST905026960.04
5708Non-cancer illness year/age first occurred | Medical conditionsUKBB000005230.04
5709Heart failure with preserved EF [Diastolic heart failure] (PheCode 428.4)GCST904759840.04
5710PCDH17/ROBO1 ratioGCST903156040.04
5711CD27/ICAM3 ratioGCST903137730.04
5712Crohn's disease NASFING000003670.04
5713Free cholesterol to total lipids ratio in very large VLDLGCST900930210.04
5714Diseases of white blood cells (PheCode 288)GCST904758120.04
5715AGXT/GRPEL1 ratioGCST903132050.04
5716ThalamNuclei lh volume CMGCST900027180.04
5717MET levelsGCST904698950.04
5718wg lh intensity-contrast parsorbitalisGCST900038100.04
5719T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 25)GCST903205880.04
5720OCLN levelsGCST904701140.04
5721T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 97)GCST903209160.04
5722total creatine kinase (mean, inv-norm transformed)GCST904764130.04
5723CD274 levelsGCST902748320.04
5724Operative procedures - Palmar fasciectomy | Summary OperationsUKBB000005860.04
5725Open biteFING000009030.04
5726Volume of left basal nucleusGCST904749460.04
5727Operation year/age first occurred | OperationsUKBB000005700.04
5728MERTK levelsGCST904698900.04
5729Phosphatidylcholine_40:6_[M+H]1+/Phosphatidylethanolamine_43:6_[M+H]1+ levelsGCST900604460.04
5730Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T490ECGA0004900.04
5731Free cholesterol in large VLDL (UKB data field 23500)GCST902695970.04
5732LY6G6C levelsGCST902418300.04
5733Contracture of palmar fascia [Dupuytren's disease] (PheCode 728.71)GCST904762450.04
5734X-24947 levelsGCST902006510.04
5735BCR/FOXO1 ratioGCST903134900.04
5736Volume of left anterior amygdaloid areaGCST904749340.04
5737Phospholipids in very large VLDL (UKB data field 23490)GCST902695870.04
5738CD40LG/EGF ratioGCST903138190.04
5739DTI autoptx MD slf r tractGCST903852420.04
5740CD55/CHI3L1 ratioGCST903138450.04
5741YOD1 levelsGCST904710900.04
5742Citrate levelsGCST900928130.04
5743Right-hemisphere control network to amygdala white-matter structural connectivityGCST903028410.04
5744Gonarthrosis, primary, with knee surgeryFING000005860.04
5745CLEC4D/CLEC6A ratioGCST903141090.04
5746High cholesterolGCST904752030.04
5747Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T175ECGU0001750.04
5748ANKMY2 levelsGCST904683090.04
5749Drusen (degenerative) of retina (PheCode 362.27)GCST904758550.04
5750IDP T1 FAST ROIs L caudateGCST900025490.04
5751ODAM levelsGCST904701150.04
5752Systemic lupus erythematosusGCST900142380.04
5753Autorefraction - 3mm cylindrical power (left) | EyesightUKBB000000620.04
5754PDGFA/SNAP23 ratioGCST903156190.04
5755Free cholesterol in small VLDLGCST904998080.04
5756T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 60)GCST903208790.04
5757Comparative height size at age 10 | Early life factorsUKBB000001430.04
5758Testosterone | Blood biochemistryUKBB000008160.04
5759Lysophosphatidylcholine_16:1_[M+H]1+/Lysophosphatidylethanolamine_19:1_[M+H]1+ levelsGCST900601480.04
5760Cholesteryl esters to total lipids ratio in small LDLGCST900929590.04
5761EDAR/PRDX5 ratioGCST903145830.04
5762WFIKKN2 levelsGCST904221270.04
5763HNRNPAB levelsGCST900886930.04
5764GDF2 levelsGCST904693220.04
5765T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 52)GCST903208710.04
5766SERPINA9 levelsGCST904705880.04
5767FEV1 FVC ratio Z score (UKB data field 20258)GCST904681650.04
5768CPA1/CTRC ratioGCST903142040.04
5769KRT5 levelsGCST904697180.04
5770Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T281ECGA0002810.04
5771Monounsaturated fatty acid levelsGCST904990940.04
5772F7/PROC ratioGCST903147440.04
5773UrolithiasisGCST900187150.04
5774Concentration of small HDL particlesGCST904994640.04
5775Triacylglycerol (54:2) [NL-18:0] levelsGCST900251750.04
5776aparc-Desikan rh volume precentralGCST900028240.04
5777Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T244ECGU0002440.04
5778Phospholipids to Total Lipids in Medium LDL percentageGCST904988520.04
5779Treatment/medication code - ramipril | MedicationsUKBB000008560.04
5780Retinal detachments and breaks | Disorders of choroid and retinaUKBB000007550.04
5781Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T155ECGU0001550.04
5782aparc-DKTatlas lh area entorhinalGCST900032380.04
5783Physical activity (Total log acceleration 2am-4am)GCST900614100.04
5784Right-hemisphere somatomotor network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903027900.04
5785CD58/MCAM ratioGCST903138520.04
5786Gonarthrosis [arthrosis of knee] | ArthrosisUKBB000002900.04
5787CCL25 levelsGCST902747680.04
5788DECR1/STX8 ratioGCST903144520.04
5789BA-exvivo lh area V2GCST900032170.04
5790NT5E levelsGCST904700930.04
5791CRTAM/VCAM1 ratioGCST903142810.04
5792Asthma (more control exclusions)FING000001130.04
5793ASAH1 levelsGCST904683730.04
5794PRKAR1A levelsGCST904703260.04
5795KIR2DL3 levelsGCST904696850.04
5796TNFRSF14 levelsGCST904709070.04
5797Leucine levelsGCST900928910.04
5798Pregnancy hypertensionFING000012040.04
5799Whole body water mass (UKB data field 23102)GCST904681840.04
5800Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T282ECGA0002820.04
5801T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 41)GCST903208600.04
5802T1 FreeSurfer BA rh V1 exvivo areaGCST903855560.04
5803Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T208ECGA0002080.04
5804Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T3ECGU0000030.04
5805Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T164ECGU0001640.04
5806Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T275ECGU0002750.04
5807Total lipids in large VLDL (UKB data field 23496)GCST902695930.04
5808NMI levelsGCST904700560.04
5809CASP3/CRKL ratioGCST903136310.04
5810wg lh intensity-contrast superiorfrontalGCST900038190.04
5811F3/GFRA1 ratioGCST903147410.04
5812Free cholesterol in VLDL (UKB data field 23420)GCST902695170.04
5813ITGB5 levelsGCST904696450.04
5814T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 80)GCST903206430.04
5815T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 7)GCST903205700.04
5816Volume of left medial nucleusGCST904748920.04
5817Hair colour (natural, before greying): Blonde (UKB data field 1747_1)GCST900418360.04
5818End-diastolic bi-ventricular shape (principal component 5)GCST904484840.04
5819Chronic sinusitisFING000002980.04
5820ST13 levelsGCST904707510.04
5821KHK levelsGCST904696750.04
5822Other diseases of oesophagus | Diseases of oesophagus, stomach and duodenumUKBB000006060.04
5823Free cholesterol to total lipids ratio in IDLGCST900928360.04
5824Cholesterol in Medium HDLGCST904984920.04
5825FGF2/HBEGF ratioGCST903148110.04
5826Paternal history of Alzheimer's diseaseGCST0059200.04
5827SUOX levelsGCST904707850.04
5828Total lipids in very large HDL (UKB data field 23552)GCST902696490.04
5829Acute pancreatitisGCST902553750.04
5830Female genital prolapseFING000005350.04
5831T1 FreeSurfer DK lh lingual thicknessGCST903856340.04
5832FLRT2 levelsGCST904692480.04
5833Intra-ocular pressure, corneal-compensated (right) | Intraocular pressureUKBB000003750.04
5834RTN4R levelsGCST904705080.04
5835Secondary thrombocytopenia (PheCode 287.32)GCST904758100.04
5836Lung function (FEV1/FVC)GCST0074310.04
5837IGFBPL1 levelsGCST901793230.04
5838Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T167ECGU0001670.04
5839Valine levelsGCST905001760.04
5840Cholesterol to total lipids in very large VLDL percentage (UKB data field 23585)GCST902696820.04
5841Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T201ECGA0002010.04
5842IDP dMRI TBSS ISOVF Corticospinal tract RGCST900044830.04
5843Triglycerides in medium VLDL (UKB data field 23508)GCST902696050.04
5844Ingrowing nail (PheCode 703.1)GCST904762080.04
5845Kyphosis (MTAG)GCST905700470.04
5846Type 2 diabetes with ophthalmic manifestations (PheCode 250.23)GCST904756730.04
5847LGMN/SPINT2 ratioGCST903153240.04
5848Cholesterol to Total Lipids in Medium LDL percentageGCST904987140.04
5849Phospholipid levels in chylomicrons and extremely large VLDLGCST905010420.04
5850Breast cancer [female] | neoplasmsUKBB000001080.04
5851CLSTN3 levelsGCST904687900.04
5852GLA levelsGCST904693540.04
5853Multiple sclerosisGCST904758330.04
5854Left bundle-branch blockFING000007160.04
5855MPHOSPH8/USP8 ratioGCST903154790.04
5856Urine taurodeoxycholic acid 3-sulfate levels in chronic kidney diseaseGCST902660450.04
5857Urinary calculus | genitourinaryUKBB000008860.04
5858Mean volume of bilateral amygdalaGCST904749010.04
5859SERPINA12 levelsGCST904705810.04
5860Phospholipids in medium LDL (UKB data field 23539)GCST902696360.04
5861TNFSF11 levelsGCST904709180.04
5862aparc-a2009s rh volume S-parieto-occipitalGCST900030630.04
5863Knee osteoarthritisGCST0070900.04
5864aparc-a2009s rh area G-oc-temp-med-LingualGCST900033920.04
5865Cholesteryl esters in chylomicrons and extremely large VLDL (UKB data field 23485)GCST902695820.04
5866Concentration of large VLDL particles (UKB data field 23495)GCST902695920.04
5867Total concentration of branched-chain amino acids (leucine + isoleucine + valine) (UKB data field 23464)GCST902695610.04
5868DTI TBSS MO Corticospinal tract RGCST903846260.04
5869Diacylglycerol_36:4_[M+H-H2O]1+ levelsGCST900601880.04
5870Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T5ECGU0000050.04
5871Disorders of breastFING000004370.04
5872Operation code - caesarean section / caesarian section | OperationsUKBB000005520.04
5873Operation code - coronary angioplasty (ptca) +/- stent | OperationsUKBB000005550.04
5874Leucine levels (UKB data field 23466)GCST902695630.04
5875Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T479ECGU0004790.04
5876SIT1 levelsGCST904706440.04
5877Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)FING000007520.04
5878Phospholipids in medium LDLGCST904988310.04
5879Abdominal aortic calcification levelsGCST901346140.04
5880Retinal thickness (functional principal component 6)GCST904557260.04
5881Phospholipids in VLDL (UKB data field 23412)GCST902695090.04
5882TTR levelsGCST904709850.04
5883Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T156ECGA0001560.04
5884DTI autoptx L2 ifo l tractGCST903851780.04
5885Volume of left central nucleusGCST904749580.04
5886GUSB levelsGCST904694210.04
5887Intrahepatic Cholestasis of Pregnancy (ICP)  (more control exclusions)FING000006920.04
5888CXCL5/MESD ratioGCST903143500.04
5889HeightGCST900187390.04
5890Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T165ECGU0001650.04
5891Fracture of rib(s), sternum and thoracic spineFING000005580.04
5892CDH5/LGALS4 ratioGCST903139560.04
5893CNPY4/MESD ratioGCST903141520.04
5894Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T170ECGU0001700.04
5895Left-hemisphere salience/ventral attention network to left-hemisphere control network white-matter structural connectivityGCST903027100.04
5896MCFD2 levelsGCST904698730.04
5897Cataract | sense organsUKBB000001200.04
5898Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T211ECGA0002110.04
5899DTI TBSS L3 Posterior corona radiata LGCST903845510.04
5900Wet age-related macular degenerationFING000014480.04
5901GGT1/IL1RL2 ratioGCST903149290.04
5902Type 1 diabetes with ophthalmic manifestations (PheCode 250.13)GCST904756630.04
5903Triglycerides in large HDLGCST904978820.04
5904T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 37)GCST903208560.04
5905ICD10 D25: Leiomyoma of uterusGCST904542040.04
5906CD209/ITGAV ratioGCST903137530.04
5907Concentration of VLDL particles (UKB data field 23428)GCST902695250.04
5908Macular cystFING000007430.04
5909Retinal detachment with retinal defect | sense organsUKBB000007540.04
5910MGLL levelsGCST904699010.04
5911ITGAL levelsGCST904696370.04
5912JAM2/THBD ratioGCST903152390.04
5913CAG-273 sp003507395 abundance in stoolGCST900322690.04
5914Psoriasis vulgarisGCST900186870.04
5915Other intervertebral disk disorders | Other dorsopathiesUKBB000006120.04
5916DTI TBSS L3 Posterior corona radiata RGCST903845500.04
5917Chronic obstructive pulmonary disease in ever smokersGCST900165880.04
5918SSNA1 levelsGCST904707500.04
5919Caries in Clefts patientsFING000002560.04
5920Monounsaturated fatty acids to total fatty acids percentageGCST905023720.04
5921Cerebrospinal fluid 3-hydroxyhexanoate levelsGCST903181080.04
5922IDP dMRI TBSS MD Posterior limb of internal capsule LGCST900040460.04
5923Pulse rate | Arterial stiffnessUKBB000007220.04
5924NPY levelsGCST904700810.04
5925aseg rh volume choroid-plexusGCST900026460.04
5926GZMA levelsGCST904694230.04
5927T1 FreeSurfer a2009s rh G cuneus volumeGCST903850480.03
5928ROR1/TNFRSF21 ratioGCST903157870.03
5929CXADR/MME ratioGCST903143290.03
5930Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T478ECGU0004780.03
5931MLN levelsGCST904699130.03
5932Left ventricular end diastole anterior wall thicknessGCST902785180.03
5933Open-angle glaucoma (PheCode 365.1)GCST904758720.03
5934aparc-pial rh area cuneusGCST900031780.03
5935ThalamNuclei lh volume VLpGCST900027340.03
5936aparc-a2009s lh area S-oc-middle+LunatusGCST900033530.03
5937Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T253ECGU0002530.03
5938VNN2 levelsGCST906185100.03
5939GPI levelsGCST902412690.03
5940Dissociative [conversion] disordersFING000004680.03
5941Left-hemisphere limbic network to hippocampus white-matter structural connectivityGCST903027400.03
5942SEMA3G levelsGCST904705710.03
59431-(1-enyl-palmitoyl)-2-oleoyl-gpc (p-16:0/18:1) levelsGCST902000570.03
5944ScoliosisFING000012810.03
5945IDP dMRI ProbtrackX FA ptr rGCST900039450.03
5946T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 105)GCST903209240.03
5947TTN levelsGCST904709840.03
5948Non-cancer illness code, self-reported - diabetes | Medical conditionsUKBB000005080.03
5949FEV1/FVC ratio | Other measurementUKBB000002450.03
5950Monounsaturated fatty acids to total fatty acids percentageGCST905020510.03
5951aparc-a2009s rh volume S-oc-temp-med+LingualGCST900030590.03
5952wg lh intensity-contrast isthmuscingulateGCST900038010.03
5953EGFR/FAP ratioGCST903146130.03
5954aparc-Desikan rh area pericalcarineGCST900031270.03
5955IDP dMRI TBSS L1 FornixGCST900040800.03
5956ANXA4/HSPB1 ratioGCST903132920.03
5957CCN5/IGFBP6 ratioGCST903137230.03
5958Optic cup areaGCST0041370.03
5959LHPP levelsGCST904697680.03
5960FABP1/LGALS4 ratioGCST903147520.03
5961Phospholipids in small VLDLGCST904998810.03
5962Operation code - appendicectomy | OperationsUKBB000005490.03
5963Disorders of the thyroid glandFING000004630.03
5964MESD/SNX9 ratioGCST903154230.03
5965Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T163ECGU0001630.03
5966CLPS levelsGCST904687860.03
5967CDHR2/MME ratioGCST903139630.03
5968Volume of left lateral nucleusGCST904749730.03
5969ECHS1 levelsGCST904690630.03
5970Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905025540.03
5971DPEP1 levelsGCST904690300.03
5972T1 CAT volume Vermis VIIIaGCST903841280.03
5973Hallux valgus (acquired)FING000006010.03
5974Diastolic blood pressureGCST903017000.03
5975EBAG9 levelsGCST904690590.03
5976Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)FING000008770.03
5977Skin colour | Sun exposureUKBB000007730.03
5978Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T73ECGU0000730.03
5979Phenylalanine levelsGCST900929360.03
5980KIAA0040 levelsGCST904225520.03
5981CholelithiasisFING000002750.03
5982Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T266ECGU0002660.03
5983THY1 levelsGCST904708610.03
5984Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T41ECGA0000410.03
5985Treatment or medication use - levothyroxine sodium (UKB data field 20003_1141191044)GCST900425350.03
5986GSTA4 levelsGCST902412830.03
5987Total esterified cholesterol levelsGCST905000360.03
5988Triglyceride levels in medium HDLGCST900929020.03
5989Left ventricular end systole anterolateral wall thicknessGCST902785110.03
5990IDP dMRI TBSS FA External capsule RGCST900039090.03
5991Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T269ECGA0002690.03
5992BA-exvivo lh area BA4pGCST900032120.03
5993FUCA1 levelsGCST904692750.03
5994AOC3 levelsGCST904683220.03
5995IDP dMRI TBSS MO Superior corona radiata LGCST900039770.03
5996X-11444 metabolite levelGCST906165450.03
5997Atrophic disorders of skinFING000001290.03
5998Retinal detachments and defects | sense organsUKBB000007560.03
5999PDCD1/TNFRSF8 ratioGCST903156100.03
6000Malignant melanomaGCST904681410.03